Fitaro Inj 1.7 mg
Semaglutide
Fitaro Inj 1.7 mg helps manage type 2 diabetes by enhancing insulin secretion, reducing blood sugar, and supporting overall glucose metabolism and energy utilization.
- Strengths 1.7
- Form Injection
- Packaging Size 1.5ml
- Packaging Type Box
- Manufacturer Incepta Pharmaceuticals Ltd
Description of Fitaro Inj 1.7 mg
Fitaro Inj 1.7 mg is a prescription injection containing Semaglutide, a GLP-1 receptor agonist used for the effective management of type 2 diabetes mellitus. It works by stimulating insulin release from the pancreas in response to elevated blood sugar, lowering glucose production in the liver, and improving cellular glucose uptake. Fitaro Inj also supports weight control and cardiovascular health when used with proper diet and exercise. It is not insulin and should not be used for type 1 diabetes or ketoacidosis. Always use under medical supervision.
Ingredients of Fitaro Inj 1.7 mg
- Active Ingredient: Semaglutide 1.7 mg
- Base: Sterile Water for Injection
Usage of Fitaro Inj 1.7 mg
- Inject once weekly, subcutaneously in the abdomen, thigh, or upper arm
- Follow dosage escalation as advised by your doctor
- Store refrigerated (2°C to 8°C), do not freeze
Precautions for Fitaro Inj 1.7 mg
- Not for type 1 diabetes or diabetic ketoacidosis
- Inform your doctor about kidney, liver, or thyroid conditions
- Monitor for signs of pancreatitis or allergic reactions
- May cause nausea, vomiting, or dizziness in early weeks
- Keep out of reach of children and use as prescribed
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
